Hunan Jingfeng Pharmaceutical Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Hunan Jingfeng Pharmaceutical Co.,Ltd. carries a market capitalization of 5.81B, placing it among publicly traded companies globally. Its enterprise value stands at 4.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.81B |
| Enterprise Value | 4.98B |
Share Statistics
Hunan Jingfeng Pharmaceutical Co.,Ltd. currently has 1.76B shares outstanding.
| Shares Outstanding | 1.76B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Hunan Jingfeng Pharmaceutical Co.,Ltd. trades at a trailing price-to-earnings ratio of 16.35. The price-to-sales ratio is 22.80, and the price-to-book ratio stands at 39.08.
| PE Ratio | 16.35 |
| PS Ratio | 22.80 |
| PB Ratio | 39.08 |
| P/TBV Ratio | 3.60 |
| P/FCF Ratio | 993.90 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 16.76 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 149.97 |
Financial Position
Hunan Jingfeng Pharmaceutical Co.,Ltd. maintains a current ratio of 4.47, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.35, indicating conservative leverage, while an interest coverage ratio of -0.89 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.47 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | -0.31 |
| Interest Coverage | -0.89 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -3.11 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -27.07 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.86 |
Taxes
Over the trailing twelve months, Hunan Jingfeng Pharmaceutical Co.,Ltd. has paid 2.18M in income taxes, reflecting an effective tax rate of 30.54.
| Income Tax | 2.18M |
| Effective Tax Rate | 30.54 |
Stock Price Statistics
Hunan Jingfeng Pharmaceutical Co.,Ltd.'s stock has gained approximately 12.54237% over the past 52 weeks. The 50-day moving average sits at 6.82, while the 200-day moving average is 7.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.54237% |
| 50-Day Moving Average | 6.82 |
| 200-Day Moving Average | 7.09 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Hunan Jingfeng Pharmaceutical Co.,Ltd. generated 297.08M in revenue and converted that into -53.32M in net income, yielding earnings per share of -0.06. EBITDA reached -22.61M, while operating income came in at -22.61M.
| Revenue | 297.08M |
| Gross Profit | 189.64M |
| Operating Income | -22.61M |
| Pretax Income | -49.88M |
| Net Income | -53.32M |
| EBITDA | -22.61M |
| EBIT | -22.61M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
Hunan Jingfeng Pharmaceutical Co.,Ltd. holds 1.75B in cash and equivalents against 7.12M in total debt, resulting in a net debt position of -1.75B. Total book value stands at 173.29M, with working capital of 1.53B providing operational flexibility.
| Cash & Cash Equivalents | 1.75B |
| Total Debt | 7.12M |
| Net Debt | -1.75B |
| Equity (Book Value) | 173.29M |
| Book Value Per Share | 0.20 |
| Working Capital | 1.53B |
Cash Flow
After subtracting -6.81M in capital expenditures, free cash flow totaled -6.81M - equivalent to -0.01 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -6.81M |
| Free Cash Flow | -6.81M |
| FCF Per Share | -0.01 |
Margins
Hunan Jingfeng Pharmaceutical Co.,Ltd. operates with a gross margin of 73.99, reflecting its pricing power and cost economics. The operating margin of -7.61 and net profit margin of -17.95 provide insight into operational efficiency.
| Gross Margin | 73.99 |
| Operating Margin | -7.61 |
| Pretax Margin | -16.79 |
| Profit Margin | -17.95 |
| EBITDA Margin | -7.61 |
Dividends & Yields
The company's payout ratio of -32.43 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.02 |
| Dividend Yield | N/A |
| Payout Ratio | -32.43 |
| Shareholder Yield | -24.12 |
| FCF Yield | 0.10 |
Stock Splits
Hunan Jingfeng Pharmaceutical Co.,Ltd.'s most recent stock split took place on June 23, 2016 with a 10:11 split ratio.
| Last Split Date | 6/23/2016 |
| Split Ratio | 10:11 |
Scores
Hunan Jingfeng Pharmaceutical Co.,Ltd. posts an Altman Z-Score of 8.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.79 |